Feature: Appetite for NPY
01 March, 2010 by Tim DeanA better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
Epilepsy, aging and malaria research big winners in 2010 NHMRC grants
25 February, 2010 by Staff Writers$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.
Patrys granted key patent for lead anti-cancer product
24 February, 2010 by Staff WritersIssued patent for lead product PAT-CM1 provides protection through the year 2023.
MicroRNA causes "double whammy" of metastasis and angiogenesis in breast cancer
23 February, 2010 by Tim DeanNew research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies.
Epigenetics makes cancer cell "lean mean machine"
22 February, 2010 by Tim DeanGarvan researchers find gene silencing in prostate cancer is more substantial than expected and could provide key to battling cancer.
Step forward in linking metals to Alzheimer’s disease
17 February, 2010 by Staff WritersStudy in mice finds significant role for zinc transport protein ZnT3 in the neurodegenerative disease.
Lorne special: Sleuthing oncogenes
16 February, 2010 by Graeme O'NeillTom Gonda’s research team at the Diamantina Institute in Brisbane is using new technology to unmask the proto-oncogenes that can cause cancer in mutant form.
Lorne special: Piecing together the breast cancer puzzle
15 February, 2010 by Fiona WylieJust when things seemed to be going around in circles, some quite unexpected data from WEHI has opened up an exciting new avenue in breast cancer research.
Lorne special: Mortality, metastasis and miRNAs
12 February, 2010 by Graeme O'NeillGreg Goodall’s Adelaide research group has explored found tantalising links between the miR-200 gene family and metastasis in a wide range of cancers.
Lorne special: Dynamic dynamin and synaptic transmission
09 February, 2010 by Fiona WylieDynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy.
Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL
20 January, 2010 by Staff WritersLiving Cell Technologies has been granted a European patent for the use of its product NTCELL in the treatment of degenerative neurological conditions.
Mesoblast generates impressive gains over Christmas
11 January, 2010 by Tim DeanMesoblast generates impressive gains over Christmas.
Unravelling kidney cancer
07 January, 2010 by Staff WritersMutations in the genome regulation machinery identified in clear cell renal cell carcinoma.
Majority of Australians shun H1N1 vaccine
05 January, 2010 by Tim DeanMany Australians confused or concerned about the swine flu vaccine. Health experts concerned about continued spread.
Gene linked to schizophrenia and bipolar disorder
16 December, 2009 by Staff WritersGene, ABCA13, has been found to be linked to schizophrenia and bipolar disorder.
